Mitochondrial Homeostasis and Signaling in Parkinson's Disease

The loss of dopaminergic (DA) neurons in the leads to a progressive, long-term decline of movement and other non-motor deficits. The symptoms of Parkinson's disease (PD) often appear later in the course of the disease, when most of the functional dopaminergic neurons have been lost. The late on...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in aging neuroscience Vol. 12; p. 100
Main Authors Scorziello, Antonella, Borzacchiello, Domenica, Sisalli, Maria Jose, Di Martino, Rossana, Morelli, Micaela, Feliciello, Antonio
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 21.04.2020
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The loss of dopaminergic (DA) neurons in the leads to a progressive, long-term decline of movement and other non-motor deficits. The symptoms of Parkinson's disease (PD) often appear later in the course of the disease, when most of the functional dopaminergic neurons have been lost. The late onset of the disease, the severity of the illness, and its impact on the global health system demand earlier diagnosis and better targeted therapy. PD etiology and pathogenesis are largely unknown. There are mutations in genes that have been linked to PD and, from these complex phenotypes, mitochondrial dysfunction emerged as central in the pathogenesis and evolution of PD. In fact, several PD-associated genes negatively impact on mitochondria physiology, supporting the notion that dysregulation of mitochondrial signaling and homeostasis is pathogenically relevant. Derangement of mitochondrial homeostatic controls can lead to oxidative stress and neuronal cell death. Restoring deranged signaling cascades to and from mitochondria in PD neurons may then represent a viable opportunity to reset energy metabolism and delay the death of dopaminergic neurons. Here, we will highlight the relevance of dysfunctional mitochondrial homeostasis and signaling in PD, the molecular mechanisms involved, and potential therapeutic approaches to restore mitochondrial activities in damaged neurons.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Ramesh Kandimalla, Texas Tech University Health Sciences Center, United States; Merina Varghese, Icahn School of Medicine at Mount Sinai, United States
Edited by: Robert Petersen, Central Michigan University, United States
ISSN:1663-4365
1663-4365
DOI:10.3389/fnagi.2020.00100